Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

Guvakova, M A

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. [electronic resource] - Cancer research Jul 1997 - 2606-10 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0008-5472


Adaptor Proteins, Signal Transducing
Adaptor Proteins, Vesicular Transport
Calcium-Calmodulin-Dependent Protein Kinases--metabolism
Cell Division--drug effects
Female
Humans
Insulin Receptor Substrate Proteins
Insulin-Like Growth Factor I--pharmacology
Mitogen-Activated Protein Kinase 1
Phosphoproteins--metabolism
Phosphorylation--drug effects
Proteins--metabolism
Receptor, IGF Type 1--metabolism
Shc Signaling Adaptor Proteins
Signal Transduction--physiology
Src Homology 2 Domain-Containing, Transforming Protein 1
Tamoxifen--pharmacology
Tumor Cells, Cultured